Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer
Despite a decline in overall incidence rates for cancer in the past decade, due in part to impressive advancements in both diagnosis and treatment, breast cancer (BC) remains the leading cause of cancer-related deaths in women. BC alone accounts for ?30% of all new cancer diagnoses in women worldwid...
Main Authors: | Margarite D. Matossian, Alexandra A. Giardina, Maryl K. Wright, Steven Elliott, Michelle M. Loch, Khoa Nguyen, Arnold H. Zea, Frank H. Lau, Krzysztof Moroz, Adam I. Riker, Steven D. Jones, Elizabeth C. Martin, Bruce A. Bunnell, Lucio Miele, Bridgette M. Collins-Burow, Matthew E. Burow |
---|---|
Format: | Article |
Language: | English |
Published: |
Mary Ann Liebert
2020-09-01
|
Series: | Women's Health Reports |
Subjects: | |
Online Access: | https://www.liebertpub.com/doi/full/10.1089/WHR.2020.0037 |
Similar Items
-
Suitability of EGCG as a Means of Stabilizing a Porcine Osteochondral Xenograft
by: Steven Elder, et al.
Published: (2017-09-01) -
Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer
by: Connor T. King, et al.
Published: (2022-06-01) -
Ceritinib is a novel triple negative breast cancer therapeutic agent
by: Shengli Dong, et al.
Published: (2022-06-01) -
Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy
by: Shengli Dong, et al.
Published: (2023-07-01) -
56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer
by: Khoa Nguyen, et al.
Published: (2021-03-01)